Clinical Trials Logo

Endometriosis clinical trials

View clinical trials related to Endometriosis.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT06268951 Enrolling by invitation - Endometriosis Clinical Trials

Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis

Start date: April 2024
Phase:
Study type: Observational

To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.

NCT ID: NCT06100471 Enrolling by invitation - Endometriosis Clinical Trials

Evaluation of Genetic Signature in Endometriosis Disease by Non Invasive Sampling

niEndometriosi
Start date: May 1, 2023
Phase:
Study type: Observational

Endometriosis is a disease that affects 10-15% of the general population and 50% of infertile women. It is characterized by the presence of endometrial tissue outside the uterine cavity. Endometriosis can lead to infertility by interfering through endocrine and mechanical alterations on the function of the ovaries, fallopian tubes, and uterus. The aim of the study is to define the differential expression of a cluster of RNAs tissue driven for the identification of an RNA profile in saliva, specific for endometriosis. This study focuses on the expression of genes involved in the control and regulation of apoptosis, cell survival, metabolism, cell adhesion and invasion, angiogenesis, inflammation, and estrogen receptor expression levels.

NCT ID: NCT05749341 Enrolling by invitation - Endometriosis Clinical Trials

A Liquid Biopsy Diagnostic Techniques for Endometriosis

Start date: April 10, 2023
Phase:
Study type: Observational

To evaluate the diagnostic efficiency of circulating endometrial cell detection method using microfluidic chip as an non-invasive method for diagnosis in endometriosis.

NCT ID: NCT05623332 Enrolling by invitation - Endometriosis Clinical Trials

Assessment of Integrin Expression in Endometriosis

Start date: November 1, 2022
Phase:
Study type: Observational

Endometriosis is a common gynaecological disease affecting 10% of the female population due to the presence of uterus-like tissue outside of the uterus, often in the pelvis. The disease causes severe lower abdominal pain mostly during the monthly period, during or after sexual intercourse, and when emptying the bowel and bladder. Currently, imaging methods such as ultrasound are ineffective at diagnosing the most common type of endometriosis, pelvic endometriosis. Therefore, we are heavily reliant on invasive surgery to make the diagnosis. This study aims to investigate the presence of binding proteins (integrins) in endometriotic tissue which will expand our understanding of endometriosis and could be used as a target to develop a non-invasive imaging test in the future. Women with symptoms consistent with endometriosis, who are due to undergo surgery to diagnose endometriosis at the EndoCare Unit in Oxford, will be eligible to participate. To attempt to visualise the integrins, participants will be asked to attend 2-7 days before their surgery to undergo an imaging scan with a molecular marker that has been found to highlight integrins in other conditions. The possibility of machine learning enhancement of integrin expression will be tested. The findings on the scan will be compared to the findings at surgery. Samples during surgery of endometriosis tissues, the endometrium, and salty water that has been flushed through the uterus, will be analysed in the lab to look for differences in the amount of integrin present in women with and without endometriosis and whether factors such as the phase of the menstrual cycle or hormonal treatment effect the amount seen.

NCT ID: NCT05601596 Enrolling by invitation - Endometriosis Clinical Trials

Research OutSmarts Endometriosis II Study

ROSE2
Start date: May 27, 2022
Phase:
Study type: Observational

This product will be used as a diagnostic test to screen for the likelihood of endometriosis in menstruating adults with symptoms suggestive of endometriosis. The purpose of the test will be to guide clinical decisions regarding: 1) whether to undergo diagnostic laparoscopy to confirm the presence of endometriosis (currently, the gold standard for diagnosing endometriosis) and/or 2) how to guide the choice of hormonal or other therapies to treat symptoms of endometriosis.

NCT ID: NCT05523284 Enrolling by invitation - Endometriosis Clinical Trials

Combining Ultrasound and Biomarkers to Diagnose Superficial Endometriosis

SPGENDO
Start date: November 15, 2023
Phase:
Study type: Observational

Endometriosis is a benign gynecological disease characterized by uterine-like cells growing outside the uterus, leading to pain, infertility, and inflammation. Endometriosis most commonly occurs in the forms of Superficial Endometriosis (SE), Deep Endometriosis and Ovarian Endometriosis (Endometrioma) (OE). Ultrasound diagnosis of DE and OE has become more reliable with advances in ultrasound technology, technique and expertise, leading to decreased diagnosis time for patients and allowing for better optimization of surgeries if required. SE, however, lacks any reliable non-invasive diagnosis methods. SE is the most common form of endometriosis and is defined as a disease that lines the peritoneum and is small and superficial in nature, leading to chronic inflammation, infertility, and pain. SE is difficult to visualize on ultrasound due to its size and alignment with tissue, requiring fluid to expand the pelvis and partially suspend these small lesions, allowing them to be diagnosed through ultrasound. Leonardi et al. observed that in some patients, a physiologic change occurs whereby fluid fills the pouch of Douglas (POD), allowing increased visualizing during ultrasound. This led to the development of Saline-infused sonoPODgraphy (SPG), a novel method utilizing modified commonly used ultrasound techniques called saline-infusion sonohysterography (SIS) and hysterosalpingo-contrast-sonography (HyCoSy), to reliably visualize the POD (Leonardi et al, 2019). Visualizing the POD is important as SE is often deposited in the POD. This diagnostic accuracy pilot study aims to pioneer the technique whereby SPG will be evaluated as a novel, rapid, non-invasive diagnostic tool for SE. The injected fluid from the POD will be withdrawn and evaluated for novel biomarkers, allowing us to further develop rapid diagnostics and better understand disease mechanisms. We hypothesize that SPG will allow for the diagnosis of SE with a diagnostic accuracy parallel to the current invasive gold standard, laparoscopy.

NCT ID: NCT05411549 Enrolling by invitation - Endometriosis Clinical Trials

The Role of a Mediterranean Diet in Patients With Endometriosis: a Feasibility Trial

MDIE
Start date: August 22, 2023
Phase: N/A
Study type: Interventional

This study aims to test if making changes to diet can affect the pelvic pain associated with endometriosis. One group will follow a Mediterranean diet for 12 weeks while the control group will continue with their current diet. We will be looking at the feasibility of a larger-scale trial as well as self-reported quality of life and self-reported pain using standardized questionnaires, that have previously been used and validated, and assessing how this diet affects biomarkers associated with endometriosis and inflammation. Further, we will test how this change in diet affects the gut microbe flora.

NCT ID: NCT04347135 Enrolling by invitation - Endometriosis Clinical Trials

Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI

Start date: October 7, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Researchers are trying to improve the detection of endometriosis using F-18 FES PET/MRI imaging.

NCT ID: NCT02911090 Enrolling by invitation - Endometriosis Clinical Trials

Endometriosis Pelvic Pain Interdisciplinary Cohort Data Registry

EPPIC
Start date: June 2016
Phase:
Study type: Observational [Patient Registry]

The purpose of this data registry is to prospectively collect data from patients referred to an interdisciplinary clinic for pelvic pain and endometriosis to investigate long-term patient outcomes, prognosis, predictors, causes, and treatment of pelvic pain and endometriosis.

NCT ID: NCT02472873 Enrolling by invitation - Endometriosis Clinical Trials

Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas

EASLETE
Start date: June 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of aspiration and sclerotherapy during laparoscopy using 95% ethanol for the treatment of endometriomas, compared to the standard cystectomy treatment - a prospective case control study.